Literature DB >> 11441141

Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE.

C Y Lin1, Z H Huang, T Mazzone.   

Abstract

Endogenous expression of apolipoprotein (apo)E in macrophages facilitates cholesterol efflux in the presence and absence of extracellular sterol acceptors. A proteoglycan-associated pool of apoE has also been described. The relationship between a proteoglycan-associated pool of apoE and enhanced cholesterol efflux was investigated in these studies. Inhibition of proteoglycan expression reduced cholesterol efflux from apoE-expressing cells ( J774E(+)) in the presence and absence of HDL, but did not do so from nonexpressing cells ( J774E(-)). The effect of proteoglycan depletion on sterol efflux from J774E(+) cells was confirmed by measuring differences in cell sterol mass, secreted sterol mass, and sterol efflux rates. Furthermore, apoE-containing particles secreted from proteoglycan-depleted J774E(+) cells were denser than those secreted from J774E(+) cells with intact proteoglycan expression. Also, in J774E(+) cells with intact proteoglycans, apoE particles isolated from the cell surface proteoglycan layer were denser than secreted particles. The apoE-lipid particles isolated from the cell surface proteoglycan layer had a lower lipid-to-apoE and cholesterol-to-apoE ratio compared with secreted particles. In distinction, proteoglycan depletion of J774E(-) cells did not reduce sterol efflux produced by the exogenous addition of apoE. These observations indicate that one mechanism by which endogenous expression of apoE facilitates effective cholesterol efflux from macrophages is related to its retention at the cell surface in a proteoglycan-associated pool. Further, our data suggest that apoE arrives at the cell surface in a relatively lipid-poor state, and that a proximate source of lipid available to the proteoglycan-bound apoE at the cell surface resides in the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441141

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

Review 1.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

2.  ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice.

Authors:  Zhi H Huang; Catherine A Reardon; Papasani V Subbaiah; Godfrey S Getz; Theodore Mazzone
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

3.  Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.

Authors:  Yuko Yamauchi; Noriko Deguchi; Chika Takagi; Masafumi Tanaka; Padmaja Dhanasekaran; Minoru Nakano; Tetsurou Handa; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

4.  Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.

Authors:  Bart Lammers; Ying Zhao; Menno Hoekstra; Reeni B Hildebrand; Dan Ye; Illiana Meurs; Theo J C Van Berkel; Miranda Van Eck
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

Review 5.  Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.

Authors:  C S Paththinige; N D Sirisena; Vhw Dissanayake
Journal:  Lipids Health Dis       Date:  2017-06-02       Impact factor: 3.876

Review 6.  Apoprotein E and Reverse Cholesterol Transport.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 7.  Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation.

Authors:  Laura Bouchareychas; Robert L Raffai
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.